Literature DB >> 29222369

Introduction: Standards of Medical Care in Diabetes-2018.

.   

Abstract

Entities:  

Year:  2018        PMID： 29222369     DOI： 10.2337/dc18-Sint01

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  91 in total

1.  Impact of Medicare Continuous Subcutaneous Insulin Infusion Policies in Patients With Type 1 Diabetes.

Authors:  Nicholas B Argento; Jingwen Liu; Allyson S Hughes; Alicia H McAuliffe-Fogarty
Journal:  J Diabetes Sci Technol       Date:  2019-03-31

2.  Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.

Authors:  M Bordbar; H Bozorgi; F Saki; S Haghpanah; M Karimi; A Bazrafshan; O R Zekavat
Journal:  J Endocrinol Invest       Date:  2019-06-21       Impact factor: 4.256

3.  The Accuracy of Continuous Glucose Monitoring and Flash Glucose Monitoring During Aerobic Exercise in Type 1 Diabetes.

Authors:  Dessi P Zaharieva; Michael C Riddell; Joseph Henske
Journal:  J Diabetes Sci Technol       Date:  2018-10-07

4.  Hypoglycemia Incidence and Factors Associated in a Cohort of Patients With Type 2 Diabetes Hospitalized in General Ward Treated With Basal Bolus Insulin Regimen Assessed by Continuous Glucose Monitoring.

Authors:  Ana María Gómez; Angélica Imitola Madero; Diana Cristina Henao Carrillo; Martín Rondón; Oscar Mauricio Muñoz; Maria Alejandra Robledo; Martín Rebolledo; Maira García Jaramillo; Fabian León Vargas; Guillermo Umpierrez
Journal:  J Diabetes Sci Technol       Date:  2019-01-24

5.  Continued Disparities in Postpartum Follow-Up and Screening Among Women With Gestational Diabetes and Hypertensive Disorders of Pregnancy: A Systematic Review.

Authors:  Emily J Jones; Teri L Hernandez; Joyce K Edmonds; Erin P Ferranti
Journal:  J Perinat Neonatal Nurs       Date:  2019 Apr/Jun       Impact factor: 1.638

Review 6.  Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both?

Authors:  Rosalie A Scholtes; Michaël J B van Baar; Yuliya Lytvyn; Petter Bjornstad; Max Nieuwdorp; David Z I Cherney; Daniël H van Raalte
Journal:  Diabetes Obes Metab       Date:  2019-04       Impact factor: 6.577

7.  High Prevalence of Undiagnosed Hyperglycemia in Low-Income Overweight and Obese Hispanic Women in Oregon.

Authors:  Nangel M Lindberg; Sonia Vega-López; Erin S LeBlanc; Michael C Leo; Victor J Stevens; Sara Gille; Mayra Arias-Gastélum; Elizabeth Shuster; Richard Meenan; Katherine A Vaughn; Meagan C Shaw; Ann Turner
Journal:  J Racial Ethn Health Disparities       Date:  2019-03-11

8.  Improvement of Blood Samples Preanalytic Management Alters the Clinical Results of Glucose Values: Population Study.

Authors:  Shlomi Codish; Doron Amichay; Maayan Yitshak-Sade; Roni Gat; Idit F Liberty; Lena Novack
Journal:  J Diabetes Sci Technol       Date:  2019-01-15

9.  Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.

Authors:  Dessi P Zaharieva; Kamuran Turksoy; Sarah M McGaugh; Rubin Pooni; Todd Vienneau; Trang Ly; Michael C Riddell
Journal:  Diabetes Technol Ther       Date:  2019-05-06       Impact factor: 6.118

10.  Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial.

Authors:  Tanya N Turan; Jenifer H Voeks; Marc I Chimowitz; Ana Roldan; Todd LeMatty; William Haley; Maria Lopes-Virella; Seemant Chaturvedi; Michael Jones; Donald Heck; George Howard; Brajesh K Lal; James F Meschia; Thomas G Brott
Journal:  Stroke       Date:  2020-09-21       Impact factor: 7.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.